$ONCO Balance Sheet | Understand Stock

$ONCO

$0.49 +$0.02 (4.07%) Pre-market

$ONCO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Aug 13, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022
Current assets
Cash
Restricted cash
Accounts receivable, net
Inventories
Deferred offering costs
Receivable from related parties
Receivable from related parties, net
Investor receivable
Related Party
Total investor receivable
Prepaid expenses and other current assets
Total current assets

Prepaid expenses, long-term
Property and equipment, net
Deposit
Deferred offering costs
Operating right of use asset
Intangible assets, net
Goodwill
Total assets
Current liabilities
Accounts payable
Accrued expenses
Notes payable, net of debt discount of $569,907
Notes payable
Related Party
Total notes payable
Operating lease liability, current
Subscription agreement liability – Related Party
Related Party
Total subscription agreement liability – Related Party
Contingent warrant liabilities
Warrant liabilities
Due to Shareholders
Derivative liabilities
Total current liabilities
Note payable, net of current maturities and debt discount of $462,518
Note payable, net of current portion
Subscription agreement liability – related party
Related Party
Total subscription agreement liability – related party
Subscription agreement liability, long-term related party
Related Party
Total subscription agreement liability, long-term related party
Pension benefit obligation
Operating lease liability, net of current portion
Deferred tax liability, net
Total liabilities
Series C Redeemable Preferred Stock, $0.00001 par value, 10,000 shares authorized, 7 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Series B Convertible Redeemable Preferred stock
Series C Redeemable Preferred Stock
Total series C Redeemable Preferred Stock, $0.00001 par value, 10,000 shares authorized, 7 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Stockholders’ equity
Common stock, $0.00001 par value, 250,000,000 shares authorized at June 30, 2026 and December 31, 2025; 3,793,676 and 31,201 shares issued at June 30, 2026 and December 31, 2025, respectively; 3,793,673 and 31,198 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Treasury stock, at cost; 12,934 shares of common stock at December 31, 2024 and 2023
Treasury stock, at cost; 3 shares of common stock at June 30, 2026 and December 31, 2025
Due from shareholders
Accumulated deficit
Accumulated other comprehensive loss
Total Onconetix, Inc. stockholders’ equity (deficit)
Non-controlling interest
Total stockholders’ equity
Total liabilities, convertible preferred stock, and stockholders’ equity

Comments